Meridian Bioscience Inc. (NASDAQ:VIVO) has been given a consensus rating of “Hold” by the seven ratings firms that are presently covering the company. One equities research analyst has rated the stock with a sell recommendation and six have given a hold recommendation to the company. The average 12 month target price among analysts that have […]
